Shandong Shengyuan Peptide Technology
Ordered peptides from Shandong Shengyuan Peptide Technology? Mail in a sample (US only) and let us test it.
Test my supplyShandong Shengyuan Peptide Technology shows a current but uneven purity-focus record, with Tirzepatide carrying the stronger signal and Retatrutide lagging. Recent results improved for both, yet Tirzepatide includes purity and identity/0 mg misses, Retatrutide has purity and large overfill failures, and batch-ID gaps limit confidence.
We investigated who actually operates Shandong Shengyuan Peptide Technology — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Shandong Shengyuan Peptide Technology rows.
Cancel anytime
Ordered peptides from Shandong Shengyuan Peptide Technology? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
30 Jul 2026 | Pass | Tirzepatide Shandong Shengyuan Peptide Technology | lab name | View COA | |||
20 Jul 2026 | Fail | Retatrutide Shandong Shengyuan Peptide Technology | lab name | View COA | |||
13 May 2026 | Pass | Tirzepatide Shandong Shengyuan Peptide Technology | lab name | View COA | |||
29 Mar 2026 | Pass | Tirzepatide Shandong Shengyuan Peptide Technology | lab name | View COA | |||
19 Mar 2026 | Pass | Retatrutide Shandong Shengyuan Peptide Technology | lab name | View COA | |||
18 Mar 2026 | Pass | Tirzepatide Shandong Shengyuan Peptide Technology | lab name | View COA | |||
25 Feb 2026 | Pass | Tirzepatide Shandong Shengyuan Peptide Technology | lab name | View COA | |||
23 Feb 2026 | Pass | Tirzepatide Shandong Shengyuan Peptide Technology | lab name | View COA | |||
20 Feb 2026 | Fail | Retatrutide Shandong Shengyuan Peptide Technology | lab name | View COA | |||
20 Feb 2026 | Fail | Retatrutide Shandong Shengyuan Peptide Technology | lab name | View COA | |||
About Shandong Shengyuan Peptide Technology test results from Finnrick
Shandong Shengyuan Peptide Technology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 30 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Shandong Shengyuan Peptide Technology peptides in this dataset are Retatrutide (11 tests), Tirzepatide (19 tests) and Cagrilintide (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 30 recent tests.
Ordered peptides from Shandong Shengyuan Peptide Technology? Mail in a sample (US only) and let us test it.
Test my supply